Start with the basics: get a handle on what AI is, why it matters, and how it’s used in the real world. Make a plan: figure ...

Algebra Ace releases '9th Grade Algebra Made Easy,' an affordable interactive guide using Desmos technology to help visual ...

This study included six (15%) patients with chronic myelomonocytic leukaemia: five with dysplastic and one with proliferative type chronic myelomonocytic leukaemia according to the ...

A study of data from 2,000 students highlights the best strategies for catching kids up and ensuring they pass this key subject.

Pasithea Therapeutics Presents Updated Interim Data from Ongoing Phase 1 Study of PAS-004 at the ASCO Annual Meeting 2025 Provided by GlobeNewswire Jun 2, 2025, 12:02:00 PM ...

Intellia Announces Positive Two-Year Follow-Up Data from Ongoing Phase 1 Study of Nexiguran Ziclumeran (nex-z), in Patients with Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy at ...

REDWOOD CITY, Calif., May 14, 2025--Arcellx, Inc. (NASDAQ: ACLX), a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer ...

A study co-led by Indiana University School of Medicine researchers presents a potential new strategy to prevent or slow the progression of Type 1 diabetes by targeting an inflammation-related ...

MINNEAPOLIS, May 03, 2025 (GLOBE NEWSWIRE) -- Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), presented significant ...

TGW101 is being evaluated in an ongoing, open-label, multicenter, phase 1 dose-escalation study for the treatment of patients with advanced solid tumors. The primary end points of the trial are to ...

A 2015 study found that a brief experiment by California to enroll all eighth graders in algebra backfired, lowering test scores in large districts, though it had little effect on small and mid ...

Corbus Pharmaceuticals announced results from its first-in-human dose escalation study of CRB-701, presented at the ASCO GU 2025 conference. This Phase 1 study assessed the efficacy and safety of ...